161 related articles for article (PubMed ID: 21274335)
21. Severe islet amyloidosis in congenital generalized lipodystrophy.
Garg A; Chandalia M; Vuitch F
Diabetes Care; 1996 Jan; 19(1):28-31. PubMed ID: 8720529
[TBL] [Abstract][Full Text] [Related]
22. Genetic basis of lipodystrophies and management of metabolic complications.
Agarwal AK; Garg A
Annu Rev Med; 2006; 57():297-311. PubMed ID: 16409151
[TBL] [Abstract][Full Text] [Related]
23. High bone mass associated with berardinelli lipodystrophy.
Bandeira FF; Miranda CR; Waechter C; Bandeira ME
Endocr Pract; 2007; 13(7):764-9. PubMed ID: 18194934
[TBL] [Abstract][Full Text] [Related]
24. Congenital generalized lipodystrophy in a 4-month-old infant.
Lee IH; Chen HL; Jeng YM; Cheng MT; Tsao LY; Chang MH
J Formos Med Assoc; 2001 Sep; 100(9):623-7. PubMed ID: 11695279
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy).
Mørk NJ; Rajka G; Halse J
Acta Derm Venereol; 1986; 66(2):173-4. PubMed ID: 2424246
[TBL] [Abstract][Full Text] [Related]
26. Progressive Generalized Lipodystrophy as a Manifestation of Autoimmune Polyglandular Syndrome Type 1.
Sorkina E; Frolova E; Rusinova D; Polyakova S; Roslavtseva E; Vasilyev E; Petrov V; Tiulpakov A
J Clin Endocrinol Metab; 2016 Apr; 101(4):1344-7. PubMed ID: 26891119
[TBL] [Abstract][Full Text] [Related]
27. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
28. Congenital generalized lipodystrophy, a case report.
Wacharasindhu S; Veerakul K; Likitmaskul S; Punnakanta L; Angsusingha K; Tuchinda C; Wasant P
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():44-6. PubMed ID: 8629139
[TBL] [Abstract][Full Text] [Related]
29. Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report.
Nagayama A; Ashida K; Moritaka K; Hidaka M; Gobaru M; Tanaka S; Hasuzawa N; Akasu S; Goto Y; Motomura S; Hara K; Tsuruta M; Wada N; Nakayama H; Tajiri Y; Nomura M
J Endocr Soc; 2019 Nov; 3(11):2179-2183. PubMed ID: 31720553
[TBL] [Abstract][Full Text] [Related]
30. A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities.
Ozgen Saydam B; Sonmez M; Simsir IY; Erturk MS; Kulaksizoglu M; Arkan T; Hekimsoy Z; Cavdar U; Akinci G; Demir T; Altay CT; Mihci E; Secil M; Akinci B
Endocr Res; 2019; 44(1-2):46-54. PubMed ID: 30182761
[TBL] [Abstract][Full Text] [Related]
31. A YOUNG ADULT WITH GENERALIZED LIPODYSTROPHY AND DIABETES MELLITUS (CASE REPORT).
Çelo E; Kalari B; Toti F
Georgian Med News; 2018 Apr; (277):27-31. PubMed ID: 29745909
[TBL] [Abstract][Full Text] [Related]
32. Retinal pigment epithelial change and partial lipodystrophy.
Davis TM; Holdright DR; Schulenberg WE; Turner RC; Joplin GF
Postgrad Med J; 1988 Nov; 64(757):871-4. PubMed ID: 3255937
[TBL] [Abstract][Full Text] [Related]
33. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
[TBL] [Abstract][Full Text] [Related]
34. Familial partial lipodystrophy.
Patel P; Starkey R; Maroon M
Cutis; 2002 Jul; 70(1):65-9. PubMed ID: 12184676
[TBL] [Abstract][Full Text] [Related]
35. Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia.
Simha V; Garg A
J Clin Endocrinol Metab; 2002 Feb; 87(2):776-85. PubMed ID: 11836320
[TBL] [Abstract][Full Text] [Related]
36. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.
Polyzos SA; Perakakis N; Mantzoros CS
Metabolism; 2019 Jul; 96():66-82. PubMed ID: 31071311
[TBL] [Abstract][Full Text] [Related]
37. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
[TBL] [Abstract][Full Text] [Related]
38. Congenital generalized lipodystrophy.
Najjar SS; Salem GM; Idriss ZH
Acta Paediatr Scand; 1975 Mar; 64(2):273-9. PubMed ID: 165654
[TBL] [Abstract][Full Text] [Related]
39. The complement abnormalities of lipodystrophy.
Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
[TBL] [Abstract][Full Text] [Related]
40. Diseases of adipose tissue: genetic and acquired lipodystrophies.
Capeau J; Magré J; Lascols O; Caron M; Béréziat V; Vigouroux C; Bastard JP
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1073-7. PubMed ID: 16246048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
